Latest Ratios: P/E Ratio 17.8x · EV/EBITDA 12.5x · ROE 25.9%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $7.4B | $6.5B | $5.1B | $5.2B | $3.1B | $3.7B | $4.4B | $5.4B | $4.8B | $4.7B | $5.0B |
| Enterprise Value | $8.3B | $7.3B | $6.0B | $5.9B | $4.1B | $4.8B | $4.9B | $6.0B | $5.5B | $5.2B | $5.3B |
| P/E Ratio → | 17.84 | 15.46 | 10.96 | 13.50 | 11.20 | 19.35 | 16.16 | 21.37 | 20.26 | 24.71 | 20.63 |
| P/S Ratio | 2.73 | 2.37 | 1.81 | 1.94 | 1.13 | 1.56 | 2.17 | 2.48 | 2.08 | 2.14 | 2.45 |
| P/B Ratio | 4.18 | 3.63 | 3.46 | 4.86 | 4.09 | 4.84 | 5.75 | 7.95 | 9.71 | 7.83 | 10.39 |
| P/FCF | 15.16 | 13.13 | 10.93 | 9.90 | 59.52 | 42.66 | 22.88 | 19.56 | 38.58 | 50.04 | 23.86 |
| P/OCF | 13.09 | 11.34 | 9.72 | 9.07 | 28.74 | 22.30 | 15.36 | 16.11 | 24.03 | 19.39 | 14.21 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.69 | 2.17 | 2.17 | 1.50 | 2.05 | 2.44 | 2.74 | 2.38 | 2.38 | 2.60 |
| EV / EBITDA | 12.51 | 11.01 | 8.53 | 10.43 | 9.47 | 12.82 | 12.41 | 14.14 | 13.83 | 12.50 | 13.13 |
| EV / EBIT | 15.33 | 13.49 | 9.41 | 11.12 | 10.82 | 17.16 | 13.74 | 16.64 | 17.20 | 15.50 | 14.83 |
| EV / FCF | — | 14.93 | 13.05 | 11.07 | 78.97 | 55.97 | 25.75 | 21.62 | 44.24 | 55.56 | 25.35 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.5% | 31.5% | 31.8% | 28.6% | 23.2% | 23.2% | 29.6% | 28.8% | 25.6% | 29.2% | 33.2% |
| Operating Margin | 20.0% | 20.0% | 21.2% | 17.9% | 12.8% | 10.9% | 15.5% | 15.4% | 12.8% | 15.3% | 17.7% |
| Net Profit Margin | 15.4% | 15.4% | 16.6% | 14.4% | 10.1% | 8.1% | 13.5% | 11.6% | 10.3% | 8.7% | 11.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 25.9% | 25.9% | 36.4% | 42.3% | 36.7% | 25.1% | 37.5% | 43.4% | 43.0% | 35.1% | 55.9% |
| ROA | 12.6% | 12.6% | 17.0% | 16.5% | 11.3% | 8.5% | 14.2% | 14.2% | 13.8% | 12.2% | 18.0% |
| ROIC | 16.0% | 16.0% | 21.4% | 20.8% | 14.4% | 12.0% | 18.2% | 20.7% | 19.0% | 26.3% | 34.3% |
| ROCE | 18.7% | 18.7% | 25.1% | 24.6% | 18.6% | 14.9% | 19.5% | 22.5% | 20.7% | 26.8% | 33.8% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.54 | 0.54 | 0.72 | 0.68 | 1.43 | 1.62 | 0.89 | 1.05 | 1.57 | 1.00 | 1.05 |
| Debt / EBITDA | 1.44 | 1.44 | 1.50 | 1.31 | 2.49 | 3.27 | 1.70 | 1.69 | 1.95 | 1.44 | 1.25 |
| Net Debt / Equity | — | 0.50 | 0.67 | 0.58 | 1.34 | 1.51 | 0.72 | 0.84 | 1.42 | 0.86 | 0.65 |
| Net Debt / EBITDA | 1.33 | 1.33 | 1.39 | 1.11 | 2.33 | 3.05 | 1.38 | 1.35 | 1.77 | 1.24 | 0.78 |
| Debt / FCF | — | 1.80 | 2.12 | 1.18 | 19.45 | 13.30 | 2.87 | 2.06 | 5.66 | 5.51 | 1.50 |
| Interest Coverage | 13.70 | 13.70 | 11.18 | 14.09 | 10.88 | 8.23 | 13.58 | 12.34 | 11.86 | 15.43 | 21.45 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.53 | 2.53 | 2.75 | 2.85 | 2.81 | 1.91 | 2.87 | 2.85 | 3.00 | 2.63 | 2.84 |
| Quick Ratio | 1.33 | 1.33 | 1.40 | 1.60 | 1.32 | 1.23 | 1.59 | 1.66 | 1.54 | 1.42 | 1.78 |
| Cash Ratio | 0.19 | 0.19 | 0.21 | 0.31 | 0.16 | 0.63 | 0.40 | 0.47 | 0.27 | 0.27 | 0.65 |
| Asset Turnover | — | 0.78 | 0.89 | 1.17 | 1.15 | 0.92 | 1.04 | 1.16 | 1.35 | 1.28 | 1.45 |
| Inventory Turnover | 3.72 | 3.72 | 3.76 | 4.22 | 3.36 | 3.63 | 3.53 | 4.26 | 4.30 | 4.06 | 4.39 |
| Days Sales Outstanding | — | 56.53 | 51.80 | 58.48 | 59.90 | 60.69 | 61.06 | 55.96 | 50.19 | 55.67 | 54.66 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.4% | 1.6% | 1.9% | 1.6% | 2.7% | 2.3% | 1.9% | 1.5% | 1.7% | 1.8% | 1.5% |
| Payout Ratio | 25.3% | 25.3% | 20.7% | 21.9% | 30.1% | 45.0% | 30.8% | 32.1% | 34.3% | 43.5% | 31.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 5.6% | 6.5% | 9.1% | 7.4% | 8.9% | 5.2% | 6.2% | 4.7% | 4.9% | 4.0% | 4.8% |
| FCF Yield | 6.6% | 7.6% | 9.2% | 10.1% | 1.7% | 2.3% | 4.4% | 5.1% | 2.6% | 2.0% | 4.2% |
| Buyback Yield | 1.0% | 1.2% | 0.6% | 0.8% | 6.6% | 5.3% | 2.3% | 0.0% | 4.9% | 0.6% | 0.7% |
| Total Shareholder Yield | 2.5% | 2.8% | 2.5% | 2.4% | 9.3% | 7.7% | 4.2% | 1.5% | 6.6% | 2.3% | 2.2% |
| Shares Outstanding | — | $9M | $10M | $10M | $10M | $11M | $11M | $11M | $12M | $12M | $12M |
Secular ICE demand decline
According to current market data, NEU trades at a P/E of 17.84, which appears to command a premium relative to its historical growth profile, suggesting investors are pricing the company as a defensive cash-generative asset rather than a high-growth participant in the specialty chemicals sector.
The P/FCF multiple of 15.16 indicates that the market is paying a reasonable price for the company's consistent ability to convert earnings into free cash flow. However, the PEG ratio of 1.43 suggests that the current valuation may be stretched if the company cannot overcome the secular headwinds facing its core lubricant additive business.
Based on reported financial statements, NEU's ROIC has fluctuated between 3.2% and 8.2% over the last ten quarters, reflecting the capital-intensive nature of maintaining OEM certifications and the cyclicality inherent in the specialty chemical industry's raw material cost environment.
The recent uptick in ROIC to 8.2% in 2026Q1 suggests that the company is successfully leveraging its proprietary formulations to extract higher value from its existing asset base. Investors should monitor whether this trend is sustainable or merely a temporary result of favorable pricing pass-throughs during a period of commodity price stabilization.
As reported in quarterly filings, the company's cash conversion cycle has remained elevated, peaking at 115 days in 2025Q4, which highlights the significant time required to navigate complex supply chains and the regulatory-driven testing sequences inherent in the lubricant additive manufacturing process.
The variability in the cash conversion cycle suggests that NEU's working capital efficiency is highly sensitive to inventory management and the timing of customer payments. This volatility warrants further investigation, as it directly impacts the company's ability to maintain liquidity without relying on external financing during periods of industrial demand softening.
Based on the provided balance sheet data, NEU has maintained a disciplined debt-to-equity ratio of 0.54 as of 2025Q4, which positions the company favorably compared to more levered specialty chemical peers and provides a significant buffer against potential interest rate volatility or cyclical downturns.
The interest coverage ratio, which has remained consistently above 10x, indicates that the company's debt service obligations are well-covered by operating income. This conservative capital structure appears to be a deliberate management strategy to prioritize dividend stability and internal funding of R&D over aggressive debt-fueled expansion.
The P/E ratio is frequently misapplied to NEU, as it obscures the company's significant non-cash depreciation and amortization expenses associated with its specialized testing facilities and proprietary intellectual property, which are critical to maintaining its competitive advantage in the lubricant additive market.
Investors should instead focus on EV/EBITDA or P/FCF, as these metrics better account for the company's capital-intensive nature and its ability to generate cash regardless of accounting-based earnings fluctuations. Relying solely on P/E may lead to an incomplete assessment of the company's true earning power and its long-term value creation potential.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NEU stock.
NewMarket Corporation's current P/E ratio is 17.8x. The historical average is 13.6x. This places it at the 72th percentile of its historical range.
NewMarket Corporation's current EV/EBITDA is 12.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 8.9x.
NewMarket Corporation's return on equity (ROE) is 25.9%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 31.2%.
Based on historical data, NewMarket Corporation is trading at a P/E of 17.8x. This is at the 72th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
NewMarket Corporation's current dividend yield is 1.42% with a payout ratio of 25.3%.
NewMarket Corporation has 31.5% gross margin and 20.0% operating margin. Operating margin between 10-20% is typical for established companies.
NewMarket Corporation's Debt/EBITDA ratio is 1.4x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.